The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment-Reference-Cited by-同舟云学术

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

Published:2017-01-05 Issue:1 Volume:129 Page:82-87
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Muchtar Eli¹^ORCID,Jevremovic Dragan²,Dispenzieri Angela¹,Dingli David¹,Buadi Francis K.¹,Lacy Martha Q.¹,Gonsalves Wilson¹,Hayman Suzanne R.¹,Kapoor Prashant¹,Leung Nelson¹²³,Russell Stephen¹,Lust John A.¹,Lin Yi¹,Go Ronald S.¹,Chakraborty Rajshekhar¹⁴,Zeldenrust Steven¹,Kumar Shaji K.¹,Kyle Robert A.¹,Rajkumar S. Vincent¹,Gertz Morie A.¹^ORCID

Affiliation:

1. Division of Hematology,

2. Division of Hematopathology, Department of Laboratory Medicine and Pathology, and

3. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN; and

4. Hospitalist Services, Essentia Health St. Joseph's Hospital, Brainerd, MN

Abstract

Key Points The monotypic and polytypic PC compartments assessed by MFC are prognostic in AL amyloidosis. MFC may play a role in the definition of hematologic response to treatment.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/1/82/1398849/blood721878.pdf

Reference18 articles.

1. Flow cytometry in hematological nonmalignant disorders;Béné;Int J Lab Hematol,2016

2. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration;Nadav;Br J Haematol,2006

3. Role of Flow Cytometry in the Diagnosis and Prognosis of Plasma Cell Myeloma;Olteanu;Surg Pathol Clin,2016

4. New criteria for response assessment: role of minimal residual disease in multiple myeloma;Paiva;Blood,2015

5. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients;Hu;Chinese Med J,2014

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Magnetocardiography as a potential method of therapy monitoring in amyloidosis;Frontiers in Cardiovascular Medicine;2023-08-17

2. Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies;Biomolecules;2022-09-08

3. Impact of bone marrow minimal residual disease status on quality of organ response in systemic AL amyloidosis;American Journal of Hematology;2022-04-14

4. Diagnosis and treatment of AL amyloidosis in 2022;Canadian Hematology Today;2022-03-01

5. Monitoring Patients with Light Chain (AL) Amyloidosis during and after Therapy: Response Assessment and Identification of Relapse;Hemato;2022-01-21